APT vs SINT
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APT is a StrongBuy and SINT is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
APT’s FA Score shows that 0 FA rating(s) are green whileSINT’s FA Score has 1 green FA rating(s).
- APT’s FA Score: 0 green, 5 red.
- SINT’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
APT’s TA Score shows that 4 TA indicator(s) are bullish while SINT’s TA Score has 4 bullish TA indicator(s).
- APT’s TA Score: 4 bullish, 4 bearish.
- SINT’s TA Score: 4 bullish, 4 bearish.
Price Growth
APT (@Building Products) experienced а -1.09% price change this week, while SINT (@Medical Specialties) price change was +7.36% for the same time period.
The average weekly price growth across all stocks in the @Building Products industry was +4.49%. For the same industry, the average monthly price growth was +3.49%, and the average quarterly price growth was -8.96%.
The average weekly price growth across all stocks in the @Medical Specialties industry was +1.26%. For the same industry, the average monthly price growth was -1.11%, and the average quarterly price growth was -1.23%.
Reported Earning Dates
APT is expected to report earnings on May 07, 2025.
SINT is expected to report earnings on Mar 19, 2025.
Industries' Descriptions
@Building Products (+4.49% weekly)The industry manufactures products used in the construction of residential and commercial buildings. The process involves using materials and other products, and processing them to create finished items such as doors, windows, light fittings, floor coverings, climate control products and other building components and home improvement products. Masco Corporation, Allegion PLC and Lennox International Inc. are major manufacturers of such products.
@Medical Specialties (+1.26% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| APT | SINT | APT / SINT | |
| Capitalization | 71.5M | 2.53M | 2,828% |
| EBITDA | 5.06M | -8.4M | -60% |
| Gain YTD | -16.501 | -20.857 | 79% |
| P/E Ratio | 18.03 | 10.78 | 167% |
| Revenue | 61.2M | 890K | 6,876% |
| Total Cash | 20.4M | 6.22M | 328% |
| Total Debt | 4.85M | 1.91M | 253% |
APT | SINT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 52 | 4 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 64 Fair valued | 57 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 80 | 96 | |
PRICE GROWTH RATING 1..100 | 82 | 63 | |
P/E GROWTH RATING 1..100 | 79 | 3 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SINT's Valuation (57) in the Medical Specialties industry is in the same range as APT (64). This means that SINT’s stock grew similarly to APT’s over the last 12 months.
SINT's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as APT (100). This means that SINT’s stock grew similarly to APT’s over the last 12 months.
APT's SMR Rating (80) in the Medical Specialties industry is in the same range as SINT (96). This means that APT’s stock grew similarly to SINT’s over the last 12 months.
SINT's Price Growth Rating (63) in the Medical Specialties industry is in the same range as APT (82). This means that SINT’s stock grew similarly to APT’s over the last 12 months.
SINT's P/E Growth Rating (3) in the Medical Specialties industry is significantly better than the same rating for APT (79). This means that SINT’s stock grew significantly faster than APT’s over the last 12 months.
| APT | SINT | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 81% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 66% | 2 days ago 90% |
| Momentum ODDS (%) | 2 days ago 72% | 2 days ago 81% |
| MACD ODDS (%) | 2 days ago 85% | 2 days ago 79% |
| TrendWeek ODDS (%) | 2 days ago 72% | 2 days ago 80% |
| TrendMonth ODDS (%) | 2 days ago 70% | 2 days ago 80% |
| Advances ODDS (%) | 10 days ago 64% | 10 days ago 85% |
| Declines ODDS (%) | 5 days ago 71% | 5 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 69% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 68% | 2 days ago 90% |
APT and
Correlation & Price change
A.I.dvisor indicates that over the last year, APT has been loosely correlated with BECN. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if APT jumps, then BECN could also see price increases.
| Ticker / NAME | Correlation To APT | 1D Price Change % | ||
|---|---|---|---|---|
| APT | 100% | +1.54% | ||
| BECN - APT | 37% Loosely correlated | N/A | ||
| IR - APT | 37% Loosely correlated | +0.68% | ||
| BXC - APT | 33% Poorly correlated | +6.99% | ||
| JBI - APT | 23% Poorly correlated | +4.60% | ||
| CARR - APT | 21% Poorly correlated | +2.81% | ||
More | ||||